As of the year of 2023, the Cancer Plus was transferred to AccScience Publishing (https://www.accscience.com/journal/CP). Articles starting from Volume 5 Issue 1 (2023) will be published by AccScience Publishing, while articles from Volume 1 Issue 1 (2019) to Volume 4 Issue 3 (2022) that were previously published by Whioce Publishing will be hosted by AccScience Publishing as a courtesy and upon the agreement with Whioce Publishing, with the original distribution license being applied. Articles that have been planned to be released as Online First articles will be released and published as such by AccScience Publishing. Please contact the Editor-in-Chief for information regarding the new publisher and any submissions in progress.
Hopes and challenges: Translational medical research in bladder cancer
The novel biomarkers in the diagnosis of prostate cancer
Sandwich type biosensor of ε-subunit of FoF1-ATPase for ultrasensitive-detection of Bladder cancer cell
A Novel Monoclonal Antibody PC322 Inhibit Prostate Cancer Cell Autophagy
Survival time distribution of advanced stage metastatic melanoma among whites and minority populations in Florida, 1996-2010.